Lauxera Capital Partners — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Digital Surgery develops pulsed field ablation technologies for the treatment of atrial fibrillation, offering safer and more effective procedural options for cardiac patients.
AI & Machine LearningDigital HealthMedical Devices
Co-investors8VCBalderton CapitalXR InvestBlackRockFrstIndex Ventures+4 more
Lifen provides digital tools for accessing and managing medical documents, serving patients and healthcare providers in France.
Digital HealthHealthtechSaaSParis, FR
Alexandre Huckert(Founder)inFranck Le Ouay(Founder)in
Co-investorsAgoranovDaphniKickstart InnovationPartech VenturesSerenaCreadev+1 more
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level.
BiotechDeep TechHardwareMedical Devices
Andrea(Co-founder & Chief Scientific Officer)Gerrit(Co-founder & Director of Product Management and Marketing)Hugo(CEO)Edmee(Chief Financial Officer)Hannah(HR Director)
Co-investorsSoftBank Vision FundEuropean Investment BankGilde HealthcareIrving InvestorsPura Vida InvestmentsT. Rowe Price
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













